NEXMED DEVELOPS ROOM TEMPERATURE FORMULATION OF ALPROX-TD FOR ERECTILE DYSFUNCTION

NexMed, Inc., a developer of innovative treatments based on the NexACT technology, announced that it has confirmed the long term room temperature stability of Alprox-TD, the company's proprietary topical treatment for erectile dysfunction ("ED").
Market Wire